Insider trade

Chemed Corp. (CHE): CFO exercised options on Amount not reported

Michael D Witzeman, CFO at Chemed Corp., reported an option exercise of Amount not reported.

0
Shares · @ $469.56
Traded
Feb 13, 2026
Filed
Feb 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Feb 25, 2026Company filing · Form 8-K · ResultsReported its results
    2. Mar 12, 2026InsiderCEO sold ~$806K of CHE shares in the open market
    3. Mar 27, 2026InsiderCEO sold ~$554K of CHE shares in the open market
    4. Apr 10, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
    5. Apr 23, 2026Company filing · Form 8-K · ResultsReported its results
    6. May 1, 2026InsiderCEO sold ~$842K of CHE shares in the open market
    7. May 8, 2026InsiderDirector sold ~$26K of CHE shares in the open market
    8. May 29, 2026InsiderDirector sold ~$219K of CHE shares in the open market
    9. Jun 9, 2026InsiderDirector sold ~$603K of CHE shares in the open market
    View the official recordSEC Form 4

    How to read SEC Form 4

    Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

    Full guide: What is an SEC Form 4?

    What else is on file for Chemed Corp.

    For Chemed Corp., OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CHE page.

    How this filing works

    Explore the data

    Common questions

    Which Chemed Corp. (CHE) insider traded, and how much?

    Michael D Witzeman, CFO at Chemed Corp., reported an option exercise of Amount not reported. At $469.56.

    When did it happen, and when was it made public?

    Traded: Feb 13, 2026. Filed: Feb 17, 2026. That is 4 days between the two dates.

    Is the dollar amount exact?

    It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

    Where does this information come from?

    From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

    What else has been disclosed about Chemed Corp. recently?

    For Chemed Corp., OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the CHE page.

    Does this mean CHE stock is a buy or a sell?

    No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

    Is OQRO free?

    Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

    Other disclosures at Chemed Corp.

    Everything OQRO holds on this company is on its CHE page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data